3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
3
Melanoma
3
Glioma
3
Lymphoma
2
Hematologic Neoplasms
2
Glioblastoma
2
Astrocytoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Refractory Differentiated Thyroid Gland Carcinoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neurocytoma
1
Neuroblastoma
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Histiocytosis, Langerhans-Cell
1
Ganglioneuroma
1
Ganglioglioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Interventions
Rituximab
4
Cladribine
2
tovorafenib
1
polatuzumab vedotin
1
obinutuzumab
1
immunotoxin HA22
1
ibrutinib
1
Vemurafenib
1
Specimen Handling
1
Prednisone
1
Lenalidomide
1
Famotidine
1
Doxorubicin
1
Diphenhydramine
1
Dexamethasone
1
Cyclophosphamide
1
Calcium Dobesilate
1
CT-P10
1
Biopsy
1
Aspirin
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Hairy Cell
×
dabrafenib
×
30 days
×
Clear all
No trials found.